Moving from artificial intelligence to genuine intelligent leadership: top CEOs to watch in 2026

Major non-tech public companies delivered material outperformance in 2025 driven by restructurings, product momentum and commodity cycles: Citigroup’s Project Bora Bora has revenue tracking toward $84 billion with the stock up 67% and trading at 1.25x tangible book as regulatory burdens ease; GM beat estimates, reallocated EV/autonomy spend, executed $3.5 billion of buybacks and raised EBIT guidance with the stock up 60%; Eli Lilly became the first trillion-dollar pharma as tirzepatide sales rose 131% Y/Y and the company committed $27 billion to U.S. manufacturing. Other standouts include Goldman Sachs (recent quarter net revenues $15.2B, net earnings $4.1B, stock +50%), Amphenol (revenues +50% Y/Y, Q3 operating margin 27.5%, stock +98%, 52% dividend hike) and Freeport benefitting from a copper supercycle despite a Grasberg mine outage; risks cited include tariffs, a major mine suspension and quality/oversight issues at Boeing despite improving deliveries and a $640 billion backlog.

Analysis

Market structure: The article signals a bifurcation—AI mega-caps concentrate headline risk while a broad swath of cyclical/industrial and consumer names (APH, FCX, C, GM, RL, SBUX, NKE, TGT) are generating idiosyncratic alpha driven by product cycles, M&A and operational turnarounds. Demand pockets: copper and datacenter interconnect components show tight supply/demand (copper at ~$12k/ton LME), supporting mining and parts makers’ pricing power for 6–24 months; retail/consumer names are regaining margin via SKU and channel resets. Cross-asset: stronger commodity and corporate earnings should steepen the curve and tighten IG credit spreads by 25–75bps in a risk-on move; USD may weaken modestly if commodities rally persists, benefiting cyclicals and EM FX.

Risk assessment: Tail risks include regulatory reversals (bank consent orders reintroduced, or FDA rescind fast-track) and operational shocks (Grasberg restart delays, Boeing quality setbacks) that can erase >20–30% equity gains quickly. Time horizons: immediate (days) for earnings/FAA/FDA headlines, short-term (weeks–months) for seasonal demand and tariff impacts, long-term (quarters–years) for structural shifts (EV mix, GLP-1 market share). Hidden deps: vendor concentration for AI datacenters (APH supply chain) and China consumer recovery for RL/SBUX/NKE are single points of failure. Key catalysts: FAA production cap removals, FDA approvals (LLY/NVO timing), copper remaining >$10k/ton for 60+ days.

Trade implications: Tactical longs on Citigroup (C) and Amphenol (APH) capture regulatory rerating and AI infra secular demand; copper exposure via Freeport (FCX) is a levered play on electrification. Relative trades: long GM vs short TSLA over 6–12 months to play disciplined capital allocation and buybacks against execution risk at EV-focused peers. Options: use 3–9 month call spreads on APH and 3-month protective puts on consumer cyclicals ahead of earnings/tariff windows to control downside.

Contrarian angles: Consensus overweights AI mega-caps—rotation risk into cyclicals is underpriced; some sell-offs (Novo Nordisk) may be overdone versus GLP-1 adoption fundamentals, but regulatory/price-control risk is non-trivial. Historical parallel: post-tech concentration episodes (2001, 2009) saw durable outperformance in industrials/mining once capex and commodity cycles reaccelerated. Unintended consequences: rapid GLP-1 adoption could invite pricing regulation within 12–24 months, compressing pharma multiples irrespective of sales growth.

Key Decisions for Investors

• Establish a 2–3% long position in Citigroup (C) within 30 days: thesis = continued regulatory easing and TBV rerating; target 12-month return +30% (to ~1.6x tangible book) with stop-loss at -18% if OCC/Fed actions reverse.
• Initiate a 2% long in Amphenol (APH) via a 9–12 month call spread to capture AI/datacenter demand and M&A synergy; take profits if shares rise >30% or operating margins exceed 28% in next two quarters.
• Add 1.5–2% exposure to Freeport-McMoRan (FCX), but tranche buys: deploy 50% now and add second 50% if copper sustains >$10,500/ton for 30 consecutive trading days; reduce exposure if copper falls below $8,500.
• Implement a 6–12 month pair trade: long GM (1.5%) vs short TSLA (1.0%) to exploit GM’s buybacks, EBIT upgrades and tariff resilience; hedge pair with 3-month TSLA 10-delta puts sized to short notional to limit tail risk.